Loading
Cardiac Imaging and Diagnostics · Journal article
Nmr in Biomedicine · September 11, 2026
Raises a question worth testing. It does not answer one.
This is an exploratory cross-sectional study using machine learning to identify associations between cardiac metabolic markers (by MRS) and obesity/diabetes phenotypes. Random forest classifiers achieved 76–90% test accuracy in distinguishing disease subgroups, and Bayesian network analysis suggests potential causal pathways linking visceral fat, left ventricular mass, and cardiac energetics. The study generates hypothesis-generating evidence that metabolic imaging may add discriminatory value, but does not establish clinical utility, prospective validity, or causal proof.
Cross-sectional observational study with machine learning (random forest classification and Bayesian network structure learning). 195 subjects categorised into five groups: healthy controls, obese non-diabetic, diabetic, non-obese diabetic, and obese diabetic individuals. Setting and enrolment criteria not detailed in abstract.. Intervention: No intervention; observational analysis of MRS-derived cardiac metabolic measures and MRI cardiac imaging. n = 195.
Random forest test accuracy: 78.12% (healthy vs. obese non-diabetic), 88.57% (healthy vs. diabetic), 85.19% (healthy vs. non-obese diabetic), 90.48% (obese non-diabetic vs. obese diabetic), 76.47% (non-obese diabetic vs. obese diabetic) SHAP analysis indicates metabolic metrics (P-MRS, H-MRS) have higher predictive importance than global cardiac function metrics for diabetic heart classification Bayesian networks suggest potential causal chain: increased visceral fat → increased LV mass → decreased PCr/ATP and increased cardiac lipids
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians should view this as early-stage evidence that cardiac MRS may identify metabolic perturbations in obesity and diabetes. However, these results do not yet support clinical adoption; prospective validation against clinical outcomes, comparison to standard diagnostic tests, and confirmation in independent cohorts are required before clinical utility can be claimed.
Exploratory machine learning study using observational data to generate causal hypotheses about cardiac metabolism in obesity and diabetes; lacks a prospective design, clinical outcome validation, or comparison against established diagnostic standards.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians should view this as early-stage evidence that cardiac MRS may identify metabolic perturbations in obesity and diabetes. However, these results do not yet support clinical adoption; prospective validation against clinical outcomes, comparison to standard diagnostic tests, and confirmation in independent cohorts are required before clinical utility can be claimed.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
ABSTRACT Recent developments in magnetic resonance spectroscopy (MRS) techniques have demonstrated great potential for the quantification of myocardial energy metabolites, enabling an in‐depth glimpse into the energetic state of the heart to better explain the onset and severity of disease states. However, more evidence is required to establish its clinical impact and explanatory power compared to other diagnostic variables. In this study, random forest classification was used on data from 195 subjects to discriminate between healthy vs. obese non‐diabetic, healthy vs. diabetic, healthy vs. non‐obese diabetic, obese non‐diabetic vs. obese diabetic, and non‐obese diabetic vs. obese diabetic patient subgroups using P‐MRS and H‐MRS measurements of cardiac energetics, along with MRI measures of cardiac function, fat volumes, blood pressure, and blood glucose and cholesterol levels. Achieving 78.12%, 88.57%, 85.19%, 90.48%, and 76.47% test accuracies, SHAPs (SHapley Additive exPlanations) feature importances indicate a higher predictive impact of metabolic metrics for classifying the diabetic heart compared to global function metrics, gained through most common imaging techniques. Bayesian networks generated through structure learning of the data further suggests a potential causal association of increased visceral fat, increased LVMass resulting in decreased PCr/ATP, and increased cardiac lipid levels attributed to these disease states. Through the results, we have been able to showcase the importance of MRS measurements, both as strong features separating the diseases with clinically‐relevant accuracy and furthermore its causal connection to other cardiac parameters.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.